Aviex Technologies, LLC was founded
to develop a novel, rapid response vaccine platform for infectious diseases.

Technology Advantages


Aviex uses a novel vaccine system based on live attenuated Salmonella bacteria that have to date proven safe for use in humans or animals. The bacteria are engineered to express target antigens and deliver them to the intestinal mucosa, following oral administration. In the intestines, the bacteria are able to persist for days to weeks, during which time they continuously produce antigens (depending on the particular construct) thereby leading to a potent immune response.


Live attenuated Salmonella-based Vaccines with Simple Production Scheme